Sean Christian Schuett Rivrud: Research on Personalizing Thromboprophylaxis Published in JTH and RPTH
Sean Christian Schuett Rivrud, MD/PhD Candidate at the University Medical Center Groningen’s ICU and Department of Hematology, and Medical Student at the University of Groningen, shared a post on LinkedIn:
”This summer I had the opportunity to present the first two chapters of my PhD on personalizing thromboprophylaxis in high-risk patients at the annual conference of the International Society on Thrombosis and Haemostasis (ISTH).
Now I’m very excited that both chapters are now available online in the Journal of Thrombosis and Haemostasis (JTH) and Research and Practice in Thrombosis and Haemostasis.
A big thank you to my incredible collaborators and mentors who made this possible!
Check them out here:
High-dose postpartum thromboprophylaxis in women at high risk of pregnancy-related venous thromboembolism. Read the full article here.
Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT).Read the full article here.”
Title 1: High-dose postpartum thromboprophylaxis in women at high risk of pregnancy-related venous thromboembolism: a single-center prospective cohort study
Title 2: Predicting the risk of venous thromboembolism in critically ill patients (PROVE-IT): a model development and validation study
Authors: Sean C.S. Rivrud, Èmese R.H. Heijkoop, Marloes A.G. Holswilder–Olde Scholtenhuis, Karina Meijer
Stay updated on all science in the field of hematology with Hemostasis Today.
-
Nov 2, 2025, 14:172019 ESC/EAS Guidelines for the Management of Dyslipidaemias Discussion with Lale Tokgözoğlu and Jeanine Roeters van Lennep
-
Nov 2, 2025, 14:14Nihar Desai: Post-Transplant Dysphagia
-
Nov 2, 2025, 14:13Zia Choudhry Launchs a New Digital Education Platform Designed to Inform and Empower People Living With wAIHA
-
Nov 2, 2025, 14:13Rahul Bhargava: Landmark Study Shows Excellent Outcomes in Pediatric AML Transplant
-
Nov 2, 2025, 10:17ESO: Register for the Live WSC 2025 Highlights Webinar
-
Nov 2, 2025, 14:21Claude Franceschi: I Advise You to Understand the Hemodynamic Pathophysiology of Venous Diseases Rather than Blindly Applying Ablation Techniques or Venous Stent Placement
-
Nov 2, 2025, 14:15Krishna Aragam: Why are (DCM) and Heart Failure About Twice as Common in Individuals of Self-Identified Black Race?
-
Nov 2, 2025, 14:15Raul Santos: Waist-to-Height Ratio and Coronary Artery Calcium Incidence
-
Nov 2, 2025, 14:12Steven AR Murphy: Urolithin A Shows Immune Rejuvenation and Mitochondrial Benefits in New Trial
-
Nov 2, 2025, 10:31Cihan Ay and RIETE Investigators Team Present External Validation of the VTE-PREDICT Score
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
-
Nov 2, 2025, 14:17Anamaria B: Your Mother Still Runs Part of Your DNA
-
Nov 2, 2025, 10:57Paul Bolaji on Launching The First Centralised Nigerian National Stroke Registry
-
Nov 2, 2025, 10:03Mark Stoffels: A Stroke Can Change Lives in an Instant, But With Timely Expert Care Recovery is Possible
-
Nov 2, 2025, 09:43Louise Bannon Celebrates Barbara Adams Krolak’s 10-Year Anniversary at ISTH
-
Nov 2, 2025, 08:06Sanam Loghavi Recognized at Inaugural Women in Hematology U.S. Focus Meeting 2025